Innovating.works Conecta tu I+D

ERDERA: EUROPEAN RARE DISEASES RESEARCH ALLIANCE UNIVERZITETNI KLINICNI CENTER LJUBLJANA participó en un HORIZON EUROPE HORIZON-HLTH-2023-DISEASE-07 The European Rare Diseases Research Alliance (ERDERA) aims to improve the health and well-being of the 30 million people living with a rare...
2024-08-20 - 2031-08-31 | Financiado

B-ACTIVE: Training of young scientists in the Biological regulation of the chemokine network to improve treatm... UNIVERZITETNI KLINICNI CENTER LJUBLJANA participó en un HORIZON EUROPE HORIZON-MSCA-2022-DN-01 A number of pharmaceuticals targeting cytokine/chemokine storms in lungs are in development due to an urgent new unmet medical need strength...
2023-07-05 - 2027-12-31 | Financiado

PROMINENT: PRECISION MEDICINE PLATFORM IN NEURODEGENERATIVE DISEASE UNIVERZITETNI KLINICNI CENTER LJUBLJANA participó en un HORIZON EUROPE HORIZON-JU-IHI-2022-01-single-stage Neurodegenerative diseases are one of the most important contributors to morbidity and mortality in the elderly. In Europe, over 14 million...
2023-04-25 - 2028-04-30 | Financiado

METHYLOMIC: DNA methylation markers to predict treatment success of biologicals in Crohn’s disease. UNIVERZITETNI KLINICNI CENTER LJUBLJANA participó en un HORIZON EUROPE HORIZON-HLTH-2022-TOOL-11 Monoclonal antibodies have become a mainstay of therapy in common immune-mediated diseases (IMID) including Crohn’s disease (CD), rheumatoid...
2022-11-24 - 2026-12-31 | Financiado

SUNRISE: Strategies and Technologies for United and Resilient Critical Infrastructures and Vital Services in... UNIVERZITETNI KLINICNI CENTER LJUBLJANA participó en un HORIZON EUROPE HORIZON-CL3-2021-INFRA-01 The COVID-19 pandemic has highlighted the importance of the continuity of vital services, has shown the need to work together for the common...
2022-09-06 - 2025-09-30 | Financiado

FORTEe: Get strong to fight childhood cancer an exercise intervention for children and adolescents undergoi... UNIVERZITETNI KLINICNI CENTER LJUBLJANA participó en un H2020 H2020-SC1-BHC-2018-2020 Cancer is the first leading cause of death by non-communicable diseases in children in Europe. During cancer treatment, patients’ morbidity...
2021-02-03 - 2026-08-31 | Financiado

ENVISION: Intelligent plug and play digital tool for real time surveillance of COVID 19 patients and smart dec... UNIVERZITETNI KLINICNI CENTER LJUBLJANA participó en un H2020 H2020-SC1-PHE-CORONAVIRUS-2020-2 Within only six months, over 7.4 million people have been diagnosed with SARS-CoV-2. In the most severely hit countries, more than 10% of in...
2020-10-13 - 2023-07-31 | Financiado

DIAMONDS: Diagnosis and Management of Febrile Illness using RNA Personalised Molecular Signature Diagnosis UNIVERZITETNI KLINICNI CENTER LJUBLJANA participó en un H2020 H2020-SC1-BHC-2018-2020 Our proposal will address the challenge of bringing personalised medicine into routine use in EU healthcare systems for diagnosis and treatm...
2019-12-06 - 2025-06-30 | Financiado

EJP RD: European Joint Programme on Rare Diseases UNIVERZITETNI KLINICNI CENTER LJUBLJANA participó en un H2020 H2020-SC1-BHC-2018-2020 As recognized by the Council Recommendation 2009/C 151/02, rare diseases (RD) are a prime example of a research area that can strongly profi...
2018-12-13 - 2024-08-31 | Financiado

ImmunAID: Immunome project consortium for AutoInflammatory Disorders UNIVERZITETNI KLINICNI CENTER LJUBLJANA participó en un H2020 H2020-SC1-2016-2017 Systemic autoinflammatory diseases (SAID) encompass several rare disorders characterised by extensive clinical and biological inflammation....
2018-04-27 - 2024-10-31 | Financiado

HBM4EU: European Human Biomonitoring Initiative UNIVERZITETNI KLINICNI CENTER LJUBLJANA participó en un H2020 H2020-SC1-2016-2017 The overarching goal of the European Human Biomonitoring Initiative (HBM4EU) is to generate knowledge to inform the safe management of chemi...
2016-12-09 - 2022-06-30 | Financiado

MOPEAD: Models Of Patient Engagement for Alzheimer s Disease Sofia ref. 115985 UNIVERZITETNI KLINICNI CENTER LJUBLJANA participó en un H2020 H2020-JTI-IMI2-2015-05-two-stage The MOPEAD consortium has proposed a programme of work carefully aligned to the objectives of IMI2 Call to deliver a step-change in AD-relat...
2016-12-07 - 2019-12-31 | Financiado

PERFORM: Personalised Risk assessment in febrile illness to Optimise Real life Management across the European... UNIVERZITETNI KLINICNI CENTER LJUBLJANA participó en un H2020 H2020-PHC-2014-2015 The management of febrile patients is one of the most common and important problems facing healthcare providers. Distinction between bacteri...
2015-12-01 - 2021-06-30 | Financiado

EUthyroid: Towards the elimination of iodine deficiency and preventable thyroid related diseases in Europe UNIVERZITETNI KLINICNI CENTER LJUBLJANA participó en un H2020 H2020-PHC-2014-2015 Despite the fact that iodine deficiency (ID) can easily be prevented by iodine fortification of table salt, industrial salt and cattle food,...
2015-04-08 - 2018-05-31 | Financiado

SCIENCE: Stem Cell therapy in IschEmic Non treatable Cardiac diseasE SCIENCE UNIVERZITETNI KLINICNI CENTER LJUBLJANA participó en un H2020 H2020-PHC-2014-2015 Stem Cell therapy in IschEmic Non-treatable Cardiac diseasE (SCIENCE) With more than 17 million deaths worldwide each year, ischemic heart...
2014-12-03 - 2020-12-31 | Financiado

TARCC: Targeting alpha particle emitting radionuclides to combat cancer UNIVERZITETNI KLINICNI CENTER LJUBLJANA participó en un FP7 This project aims at improving drug delivery to cancer cells by developing targeted radiotherapy with alpha-emitting radionuclides. Alpha pa...
Financiado

ARCH: Patient specific image based computational modelling for nimprovement of short and long term outco... UNIVERZITETNI KLINICNI CENTER LJUBLJANA participó en un FP7 More than half a million people live in Europe on chronic renal replacement therapy by hemodialysis (HD). This number increases annually at...
Financiado

CREACTIVE: Collaborative REsearch on ACute Traumatic brain Injury in intensiVe care medicine in Europe UNIVERZITETNI KLINICNI CENTER LJUBLJANA participó en un FP7 Traumatic brain injury (TBI) is among the leading causes of death and disability and the main cause of death among the under-45s. Most patie...
Financiado

CULPRIT-SHOCK: Multivessel versus culprit lesion only percutaneous revascularization in patients with acute myocard... UNIVERZITETNI KLINICNI CENTER LJUBLJANA participó en un FP7 Cardiogenic shock (CS) complicating acute myocardial infarction (AMI) represents a major European health care concern with mortality rates b...
Financiado

RESPECT: Relating Expectations and needs to Participation and Empowerment of children in Clinical Trials UNIVERZITETNI KLINICNI CENTER LJUBLJANA participó en un FP7 There are two objectives for this project, firstly to clarify the expectations and needs of children and their families who have participate...
Financiado

UKCL